Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.
about
Immunology of Crohn's DiseaseEuropean evidence based consensus on the diagnosis and management of Crohn's disease: special situationsInterventions for prevention of post-operative recurrence of Crohn's diseaseProbiotics for induction of remission in Crohn's diseaseInterventions for prevention of post-operative recurrence of Crohn's diseaseProbiotics for maintenance of remission in Crohn's diseaseProbiotics for the maintenance of remission in Crohn's diseasePotential uses of probiotics in clinical practiceSynbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trialMaintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazineLactobacillus GG in inducing and maintaining remission of Crohn's diseaseNovel perspectives on therapeutic modulation of the gut microbiotaDiet therapy for inflammatory bowel diseases: The established and the newTh17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel DiseasesThe role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trialsProbiotics in inflammatory bowel diseases and associated conditionsModulation of microbiota as treatment for intestinal inflammatory disorders: An uptodateSystematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel diseaseCan probiotics modulate human disease by impacting intestinal barrier function?Medical management of Crohn's disease: current therapy and recent advances.Probiotics under the regulatory microscope.Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacyIntestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphatesGut microbiota, probiotics, and human healthUse of probiotics for prevention of radiation-induced diarrhea.Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria.Probiotics and the gastrointestinal tract: where are we in 2005?Antibiotics and probiotics in treatment of inflammatory bowel disease.Do probiotics have a therapeutic role in gastroenterology?The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonizationProbiotics and prebiotics in chronic inflammatory bowel diseases.Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cellsProbiotics-host communication: Modulation of signaling pathways in the intestine.Medical management of Crohn's disease.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Infectious etiopathogenesis of Crohn's diseaseA randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis.
P2860
Q22241677-36FF2E42-68EA-4AD6-A3E2-9FDBBC7726DCQ22242050-42BECE43-A2A1-4535-8CB9-7300437F04DEQ24240542-BF6A2830-C00A-4FBB-AEE2-955FD197E0D0Q24242115-35E07293-3ECB-4692-A611-278B2FA1175BQ24243623-5C0A935A-39E2-41BC-8DD9-A51C537ADEA6Q24244110-CE73F2CC-9FAD-4444-B4C9-71971E45D892Q24246901-E2170CB7-F970-40C3-A98A-32E4F1A34426Q24681377-B5B80C37-D570-48C0-B51A-A8615B24E36FQ24685494-62BC3652-491A-4314-AD0B-98052370D62BQ24685766-4CD1BBBF-ACFD-465B-B597-90C9B35857C4Q24806098-02168B4B-D2AA-46BF-934A-82CD7CDD2A5CQ26745706-5ABCE075-CF6B-48AE-89C5-7D31261790A6Q26768564-3253FB9F-3053-4374-9BAA-16B9CED88448Q26784194-6D9CD6AA-6CA5-412C-B40F-06CE031E3943Q27001546-39FFF896-9F0E-49CE-9524-34D81ABAEF82Q27002496-C6CBD018-6DB0-4622-84AF-F08203E884D7Q28072437-74B924D9-7E01-4C08-B1B1-2F0EE3B78857Q28254207-28932900-D41D-4486-9555-E0995BAEFC5FQ28817192-D953A66F-6966-4A02-BB09-1BD7D0337497Q30450875-4C299482-A182-4A44-957B-FBE1901506D6Q33226168-06A51F62-BD36-4173-9459-8829C4B33357Q33256876-D52E07E4-AF14-4467-8853-947DD8C53270Q33503647-205EBBB2-F73D-4C6D-B43D-16F317D408CEQ33626582-02948058-CE9E-47C1-9C02-5921FBF6D7D1Q33666412-59AE7D6D-AA5D-4A15-88E3-90876361B397Q33787744-A70B1754-5AB3-4EFB-899B-84EAF40AC65DQ33787825-64ED7C51-7D64-4DD9-AE01-FFFEF4676FCEQ33788552-29CA3F75-A14D-4808-B25D-D7EC3F718FE8Q33867934-771BD0C6-A773-4750-B83A-930C062E9D36Q33869477-11897799-7099-4FBF-8BEF-7B0032F33A52Q33919752-B4228A6B-A696-473F-A2C7-E142492F5CB5Q34013030-210D0878-8015-4A3D-BBB6-A24A18577FEDQ34013041-5B394DAF-62E9-4C13-A371-AAFC9709D8C0Q34018028-D8B572FD-5034-40E4-B7BF-265CD6683C04Q34046139-36E5C6FE-2D67-4F82-AD12-9F9028EEA5CCQ34152778-B0E4D54A-3B37-47E2-845A-A9CD1FF66C4FQ34168490-07D06300-F4AA-470A-A4F1-8643BEE7FA03Q34560319-0395883E-F86E-49AD-9D19-6A0D2F8DEC01Q34588415-E97A62A4-40E6-4697-912C-3CFE9842F3F7Q34622749-B9C5BB38-EDA3-4919-974B-85C4E978B868
P2860
Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Ineffectiveness of probiotics ...... d trial with Lactobacillus GG.
@ast
Ineffectiveness of probiotics ...... d trial with Lactobacillus GG.
@en
type
label
Ineffectiveness of probiotics ...... d trial with Lactobacillus GG.
@ast
Ineffectiveness of probiotics ...... d trial with Lactobacillus GG.
@en
prefLabel
Ineffectiveness of probiotics ...... d trial with Lactobacillus GG.
@ast
Ineffectiveness of probiotics ...... d trial with Lactobacillus GG.
@en
P2093
P2860
P356
P1433
P1476
Ineffectiveness of probiotics ...... d trial with Lactobacillus GG.
@en
P2093
P2860
P304
P356
10.1136/GUT.51.3.405
P407
P577
2002-09-01T00:00:00Z